Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Traumatic brain injury recovery

Cystatin C has a dual role in post-traumatic brain injury recovery.

Marina Martinez-Vargas; Maribel Soto-Nuñez; Erika Tabla-Ramon; Barbara Solis; Ruben Gonzalez-Rivera; Adan Perez-Arredondo; Francisco Estrada-Rojo; Andres Castell; Juan Molina-Guarneros; Luz Navarro

Originally published in International journal of molecular sciences · 2014-04-04

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Cathepsin B is one of the major lysosomal cysteine proteases involved in neuronal protein catabolism. This cathepsin is released after traumatic injury and increases neuronal death; however, release of cystatin C, a cathepsin inhibitor, appears to be a self-protective brain response. Here we describe the effect of cystatin C intracerebroventricular administration in rats prior to inducing a traumatic brain injury. We observed that cystatin C injection caused a dual response in post-traumatic brain injury recovery: higher doses (350 fmoles) increased bleeding and mortality, whereas lower doses (3.5 to 35 fmoles) decreased bleeding, neuronal damage and mortality. We also analyzed the expression of cathepsin B and cystatin C in the brains of control rats and of rats after a traumatic brain injury. Cathepsin B was detected in the brain stem, cerebellum, hippocampus and cerebral cortex of control rats. Cystatin C was localized to the choroid plexus, brain stem and cerebellum of control rats. Twenty-four hours after traumatic brain injury, we observed changes in both the expression and localization of both proteins in the cerebral cortex, hippocampus and brain stem.

Conclusions

We found that cystatin C administration caused a dual response in post-traumatic brain injury recovery. Higher doses increased damage, whereas lower doses decreased it. We also found that an early increase and intralysosomal expression of cystatin C after brain injury was associated with reduced neuronal damage. In conclusion, we believe that a fine balance between the cathepsins and Cystatin C must be maintained to achieve effective neuroprotection.

Editorial reading guide

  • How did the authors define recovery, and when did they measure it?
  • Does the outcome reflect a laboratory measure, a functional change or participation in daily life?